Michihito Sasaki

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

Rigel Suzuki, Daichi Yamasoba, Izumi Kimura et al. · Nature · 2022 · 735 citations · Full text

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · Journal of Medicinal Chemistry · 2022 · 553 citations · Full text

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

Daichi Yamasoba, Izumi Kimura, Hesham Nasser et al. · Cell · 2022 · 340 citations · Full text

Vaccination, Global Spread, Ba.2 Spike-bearing Virus +14

RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells

Taisho Yamada, Seiichi Sato, Yuki Sotoyama et al. · Nature Immunology · 2021 · 232 citations · Full text

Lung Inflammation, Immunology, Antiviral Response +5

New mutation causing hereditary hepatitis in the laboratory rat

Michihiro C. Yoshida, Ryuichi Masuda, Michihito Sasaki et al. · Journal of Heredity · 1987 · 219 citations